Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

N. Zilembo · SciRah

Researcher profile · Semantic Scholar

N. Zilembo

Share profile

N. Zilembo — researcher profile on SciRah

h-index: 32
Works: 138
Citations: 3,931

Most-cited papers

Safety and efficacy of two different doses of capecitabine in the treatment of advanced breast cancer in older women.
E. Bajetta, G. Procopio, L. Celio, L. Gattinoni +7 more
2005Journal of Clinical Oncology206 citations
Semantic Scholar
Modulation of peripheral blood immune cells by early use of steroids and its association with clinical outcomes in patients with metastatic non-small cell lung cancer treated with immune checkpoint inhibitors
G. Fucà, G. Galli, M. Poggi, Giuseppe Lo Russo +13 more
2019ESMO Open199 citations Open access
Semantic Scholar
Italian, Multicenter, Phase III, Randomized Study of Cisplatin Plus Etoposide With or Without Bevacizumab as First-Line Treatment in Extensive-Disease Small-Cell Lung Cancer: The GOIRC-AIFA FARM6PMFJM Trial.
M. Tiseo, L. Boni, F. Ambrosio, A. Camerini +15 more
2017Journal of Clinical Oncology165 citations
Semantic Scholar
Phase II study of pemetrexed and carboplatin plus bevacizumab as first-line therapy in malignant pleural mesothelioma
G. Ceresoli, P. Zucali, M. Mencoboni, M. Botta +14 more
2013British Journal of Cancer109 citations Open access
Semantic Scholar
Phase II study of asparagine-glycine-arginine-human tumor necrosis factor alpha, a selective vascular targeting agent, in previously treated patients with malignant pleural mesothelioma.
V. Gregorc, P. Zucali, A. Santoro, G. Ceresoli +15 more
2010Journal of Clinical Oncology109 citations Open access
Semantic Scholar
EPSILoN: A Prognostic Score for Immunotherapy in Advanced Non-Small-Cell Lung Cancer: A Validation Cohort
A. Prelaj, R. Ferrara, S. E. Rebuzzi, C. Proto +18 more
2019Cancers78 citations Open access
Semantic Scholar
Sorafenib with interleukin-2 vs sorafenib alone in metastatic renal cell carcinoma: the ROSORC trial
G. Procopio, E. Verzoni, S. Bracarda, S. Ricci +6 more
2011British Journal of Cancer70 citations Open access
Semantic Scholar
Treatment of lung large cell neuroendocrine carcinoma
Giuseppe Lo Russo, S. Pusceddu, C. Proto, M. Macerelli +9 more
2016Tumor Biology67 citations
Semantic Scholar
Efficacy and safety of immunotherapy in elderly patients with non-small cell lung cancer.
G. Galli, A. De Toma, F. Pagani, G. Randon +10 more
2019Lung Cancer60 citations Open access
Semantic Scholar
Pemetrexed versus pemetrexed and carboplatin as second-line chemotherapy in advanced non-small-cell lung cancer: results of the GOIRC 02-2006 randomized phase II study and pooled analysis with the NVALT7 trial.
A. Ardizzoni, M. Tiseo, L. Boni, A. Vincent +21 more
2012Journal of Clinical Oncology57 citations
Semantic Scholar
Is there evidence for different effects among EGFR-TKIs? Systematic review and meta-analysis of EGFR tyrosine kinase inhibitors (TKIs) versus chemotherapy as first-line treatment for patients harboring EGFR mutations.
E. Haspinger, F. Agustoni, V. Torri, Francesco Gelsomino +5 more
2015Critical reviews in oncology/hematology55 citations
Semantic Scholar
Targeted therapy-induced diarrhea: A review of the literature.
M. A. Pessi, N. Zilembo, E. Haspinger, Leonardo Molino +3 more
2014Critical reviews in oncology/hematology55 citations
Semantic Scholar
Poziotinib for EGFR and HER2 exon 20 insertion mutation in advanced NSCLC: Results from the expanded access program.
A. Prelaj, A. Bottiglieri, C. Proto, Giuseppe Lo Russo +18 more
2021European Journal of Cancer53 citations
Semantic Scholar
Best practices for the management of thymic epithelial tumors: A position paper by the Italian collaborative group for ThYmic MalignanciEs (TYME).
M. Imbimbo, M. Ottaviano, M. Vitali, A. Fabbri +78 more
2018Cancer Treatment Reviews50 citations Open access
Semantic Scholar
Biological activity of anastrozole in postmenopausal patients with advanced breast cancer: effects on estrogens and bone metabolism.
E. Bajetta, A. Martinetti, N. Zilembo, P. Pozzi +6 more
2002Annals of Oncology47 citations Open access
Semantic Scholar
Outcomes of First‐Generation EGFR‐TKIs Against Non‐Small‐Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Post Hoc Analysis of the BE‐POSITIVE Study
S. Pilotto, A. Rossi, T. Vavalà, A. Follador +25 more
2018Clinical Lung Cancer46 citations Open access
Semantic Scholar
Emerging toxicities in the treatment of non-small cell lung cancer: ocular disorders.
F. Agustoni, M. Platania, M. Vitali, N. Zilembo +5 more
2014Cancer Treatment Reviews46 citations Open access
Semantic Scholar
Neuroendocrine tumors of unknown primary site: Gold dust or misdiagnosed neoplasms?
L. Catena, E. Bichisao, M. Milione, M. Valente +6 more
2011Tumori43 citations
Semantic Scholar
Concomitant EML4-ALK rearrangement and EGFR mutation in non-small cell lung cancer patients: a literature review of 100 cases
Giuseppe Lo Russo, M. Imbimbo, G. Corrao, C. Proto +7 more
2017OncoTarget42 citations Open access
Semantic Scholar
A randomized, multicenter prospective trial assessing long‐acting release octreotide pamoate plus tamoxifen as a first line therapy for advanced breast carcinoma
E. Bajetta, G. Procopio, L. Ferrari, A. Martinetti +6 more
2002Cancer39 citations
Semantic Scholar
Randomized phase II three-arm trial with three platinum-based doublets in metastatic non-small-cell lung cancer. An Italian Trials in Medical Oncology study.
P. Bidoli, N. Zilembo, D. Cortinovis, L. Mariani +8 more
2006Annals of Oncology36 citations Open access
Semantic Scholar
Lung Cancer App (LuCApp) study protocol: a randomised controlled trial to evaluate a mobile supportive care app for patients with metastatic lung cancer
Oriana Ciani, M. Cucciniello, F. Petracca, G. Apolone +9 more
2019BMJ Open33 citations Open access
Semantic Scholar
Osteoprotegerin and osteopontin serum values in postmenopausal advanced breast cancer patients treated with anastrozole.
A. Martinetti, E. Bajetta, L. Ferrari, N. Zilembo +7 more
2004Endocrine-Related Cancer33 citations Open access
Semantic Scholar
Phase II Randomized Study of Vandetanib Plus Gemcitabine or Gemcitabine Plus Placebo as First-Line Treatment of Advanced Non–Small-Cell Lung Cancer in Elderly Patients
C. Gridelli, S. Novello, N. Zilembo, A. Luciani +16 more
2014Journal of Thoracic Oncology28 citations Open access
Semantic Scholar
Uncommon mutations in epidermal growth factor receptor and response to first and second generation tyrosine kinase inhibitors: A case series and literature review.
G. Galli, G. Corrao, M. Imbimbo, C. Proto +7 more
2018Lung Cancer27 citations
Semantic Scholar
Overall survival for sorafenib plus interleukin-2 compared with sorafenib alone in metastatic renal cell carcinoma (mRCC): final results of the ROSORC trial.
G. Procopio, E. Verzoni, S. Bracarda, S. Ricci +6 more
2013Annals of Oncology27 citations Open access
Semantic Scholar
Practical issues for the management of hyponatremia in oncology
R. Berardi, A. Antonuzzo, L. Blasi, R. Buosi +6 more
2018Endocrine22 citations
Semantic Scholar
Low Baseline Serum Sodium Concentration Is Associated with Poor Clinical Outcomes in Metastatic Non-Small Cell Lung Cancer Patients Treated with Immunotherapy
G. Fucà, G. Galli, M. Poggi, Giuseppe Lo Russo +11 more
2018Targeted oncology22 citations
Semantic Scholar
A prospective observational study to evaluate G-CSF usage in patients with solid tumors receiving myelosuppressive chemotherapy in Italian clinical oncology practice
S. Barni, V. Lorusso, M. Giordano, G. Sogno +9 more
2013Medical Oncology19 citations
Semantic Scholar
Italian multicenter phase III randomized study of cisplatin-etoposide with or without bevacizumab as first-line treatment in extensive stage small cell lung cancer: treatment rationale and protocol design of the GOIRC-AIFA FARM6PMFJM trial.
M. Tiseo, L. Boni, F. Ambrosio, A. Camerini +14 more
2015Clinical Lung Cancer17 citations
Semantic Scholar
Medical treatment choices for patients affected by advanced NSCLC in routine clinical practice: results from the Italian observational "SUN" (Survey on the lUng cancer maNagement) study.
C. Gridelli, A. Ardizzoni, S. Barni, L. Crinò +16 more
2011Lung Cancer17 citations
Semantic Scholar
Preclinical and clinical evaluation of four gemcitabine plus carboplatin schedules as front-line treatment for stage IV non-small-cell lung cancer.
E. Bajetta, S. Stani, D. De Candis, N. Zaffaroni +6 more
2003Annals of Oncology16 citations Open access
Semantic Scholar
BE-POSITIVE: Beyond progression after tyrosine kinase inhibitor in EGFR- positive non small cell lung cancer patients: Results from a multicenter Italian observational study.
T. Vavalà, A. Follador, M. Tiseo, D. Galetta +24 more
2016Lung Cancer15 citations Open access
Semantic Scholar
Feasibility of Sequential Therapy with FOLFIRI Followed by Docetaxel/Cisplatin in Patients with Radically Resected Gastric Adenocarcinoma
M. Di Bartolomeo, R. Buzzoni, L. Mariani, E. Ferrario +15 more
2007Oncology15 citations
Semantic Scholar
Impact of cholesterolemia and body mass index on outcome of metastatic non small cell lung cancer treated with immunotherapy.
G. Galli, P. Corsetto, R. Ferrara, A. Prelaj +11 more
2019Journal of Clinical Oncology12 citations
Semantic Scholar
The estrogen suppression after sequential treatment with formestane in advanced breast cancer patients.
N. Zilembo, E. Bajetta, E. Bichisao, A. Martinetti +6 more
2004Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie12 citations
Semantic Scholar
Bone turnover markers and insulin-like growth factor components in metastatic breast cancer: results from a randomised trial of exemestane vs megestrol acetate.
A. Martinetti, N. Zilembo, L. Ferrari, G. Massimini +9 more
2003Anticancer Research12 citations
Semantic Scholar
Small-Cell Lung Cancer: Clinical Management and Unmet Needs New Perspectives for an Old Problem.
G. Russo, M. Macerelli, M. Platania, N. Zilembo +9 more
2017Current Drug Targets11 citations
Semantic Scholar
Oxaliplatin doublets in non-small cell lung cancer: a literature review.
D. Cortinovis, P. Bidoli, N. Zilembo, A. Fusi +1 more
2008Lung Cancer10 citations
Semantic Scholar
Phase I study of escalating doses of oxaliplatin in combination with fixed dose gemcitabine in patients with non-small cell lung cancer.
P. Bidoli, S. Stani, L. Mariani, D. De Candis +6 more
2004Lung Cancer10 citations
Semantic Scholar
Short-term effects of anastrozole treatment on insulin-like growth factor system in postmenopausal advanced breast cancer patients.
L. Ferrari, A. Martinetti, N. Zilembo, P. Pozzi +9 more
2002Journal of Steroid Biochemistry and Molecular Biology10 citations
Semantic Scholar
Endocrine effects of nonsteroidal aromatase inhibitors and their clinical impact.
E. Bajetta, N. Zilembo, E. Bichisao, P. E. Lønning +2 more
2002Journal of Clinical Oncology10 citations
Semantic Scholar
Effects of antibiotic use during immunotherapy in metastatic non-small cell lung cancer.
G. Galli, M. Poggi, G. Fucà, M. Imbimbo +8 more
2018Annals of Oncology9 citations Open access
Semantic Scholar
Clinical retrospective analysis of erlotinib in the treatment of elderly patients with advanced non-small cell lung cancer
M. Platania, F. Agustoni, B. Formisano, M. Vitali +6 more
2011Targeted oncology9 citations
Semantic Scholar
Characterization of patients with metastatic non-small-cell lung cancer obtaining long-term benefit from immunotherapy.
G. Galli, C. Proto, D. Signorelli, M. Imbimbo +8 more
2019Future Oncology8 citations Open access
Semantic Scholar
A randomized, open label, prospective study comparing the association between sorafenib (So) and interleukin-2 (IL-2) versus So alone in advanced untreated renal cell cancer (RCC): Rosorc Trial.
G. Procopio, E. Verzoni, S. Bracarda, S. Ricci +6 more
2016Journal of Clinical Oncology8 citations
Semantic Scholar
Systemic Approach to Malignant Pleural Mesothelioma: What News of Chemotherapy, Targeted Agents and Immunotherapy?
D. Signorelli, M. Macerelli, C. Proto, M. Vitali +12 more
2016Tumori7 citations
Semantic Scholar
PROSE: Randomized proteomic stratified phase III study of second line erlotinib versus chemotherapy in patients with inoperable non-small cell lung cancer (NSCLC).
Cristina Sorlini, S. Barni, F. Petrelli, S. Novello +16 more
2011Journal of Clinical Oncology7 citations
Semantic Scholar
Uncommon targets in non-small cell lung cancer: everyone wants a slice of cake.
A. De Toma, G. L. Russo, D. Signorelli, F. Pagani +9 more
2021Critical reviews in oncology/hematology6 citations
Semantic Scholar
Immune-checkpoints inhibitors in metastatic non small cell lung cancer with rare histology.
D. Signorelli, R. Ferrara, C. Proto, Giuseppe Lo Russo +13 more
2019Journal of Clinical Oncology6 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Garassino×19
Invite
M. Garassino — researcher profile on SciRah
C. Proto×16
Invite
C. Proto — researcher profile on SciRah
D. Signorelli×16
Invite
D. Signorelli — researcher profile on SciRah
M. Ganzinelli×15
Invite
M. Ganzinelli — researcher profile on SciRah

Giuseppe Lo Russo

×13

Invite

Giuseppe Lo Russo — researcher profile on SciRah

F. De Braud×13

Invite

F. De Braud — researcher profile on SciRah

Invite

E. Bajetta — researcher profile on SciRah

Invite

G. Galli — researcher profile on SciRah

Invite

M. Vitali — researcher profile on SciRah

Invite

M. Imbimbo — researcher profile on SciRah

Invite

R. Ferrara — researcher profile on SciRah

Invite

A. Prelaj — researcher profile on SciRah